F. Moldovan et al., Diacerhein and rhein reduce the ICE-induced IL-1 beta and IL-18 activationin human osteoarthritic cartilage, OSTEO CART, 8(3), 2000, pp. 186-196
Objective: IL-1 beta plays a fundamental role in osteoarthritis (OA) pathop
hysiology and cartilage destruction. Targeting the activation mechanism of
this cytokine appears to be important as a therapeutic approach. As the int
erleukin-l converting enzyme (ICE) is the physiologic modulator of the prod
uction of active IL-1 beta, we investigated the effect of diacerhein and it
s active metabolite rhein used in the treatment of OA patients, on the enzy
me expression and synthesis on human OA cartilage. Further, we looked at th
e effect of both drugs on the production of the active form of IL-1 beta an
d IL-18.
Methods: The expression and synthesis of ICE were investigated on human OA
cartilage explants using in-situ hybridization and immunohistochemical meth
ods, respectively. The effect of the drugs on ICE OA chondrocytes was also
determined by Northern blotting and a specific ELISA assay. Furthermore, th
e effect of both drugs on the level of active IL-1 beta and IL-18 was exami
ned by immunohistochemistry.
Results: Data showed that diacerhein and rhein have no true effect on reduc
ing total ICE mRNA by both Northern blotting analysis and in-situ hybridiza
tion. A marked and statistically significant decrease was, however, found f
or protein production. ELISA showed a reduction of 31% (P<0.04) for diacerh
ein and 50% (P<0.02) for rhein. The drugs' immunohistological cell score re
duction was similar to data from the ELISA, and a statistical significant r
eduction of ICE production was found at both superficial and deep zones of
the cartilage. IL-1 beta and IL-18 were both preferentially produced in cho
ndrocytes of the superficial zone. For each of these cytokines, both drugs
demonstrated a statistically significant decrease in this zone. A marked de
crease was also noted in the deep zone, but statistical significance was re
ached only for rhein.
Conclusion: These results provide a novel regulatory mechanism by which dia
cerhein and rhein could exert a down-regulation on IL-l's effect on OA cart
ilage. (C) 2000 OsteoArthritis Research Society International.